{"title":"[丹参盐酸川芎嗪鼻腔热敏原位凝胶的制备及鼻腔粘膜通透性表征研究]。","authors":"Wang-qing Hao, Yu Lin, Xu Yuan, Qian Gao","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To prepare the salviae miltiorrhiza and ligustrazine hydrochloride nasal thermosensitive in situ gel and to study the characterization of its nasal mucosal permeability.</p><p><strong>Methods: </strong>With gelling temperature as the dependent variable, the contents of poloxamer 407( P407), poloxamer 188( P188) and PEG-6000 as independent variables. The best prescription was optimized by central composite design-response surface methodology. The release in vitro and the skin permeation ability were evaluated in Franz diffusion cell.</p><p><strong>Results: </strong>The optimal formulation composed with the dosage of P407,P188 and PEG-6000 were 18%,7% and 1%,respectively. The cumulative release in vitro was over 70% after 12 h, and the release curve conformed to the first-order kinetic equation. The cumulative permeation of salviae miltiorrhiza and ligustrazine hydrochloride in the gel were 2 649. 77 μg / cm2 and 119. 72 μg / cm2 after 12h.</p><p><strong>Conclusion: </strong>The central composite design-response surface methodolog was stable and feasible for preparation of nasal thermosensitive in situ gel of salviae miltiorrhiza and ligustrazine hydrochloride, the drug-loaded gel has sustained release effect.</p>","PeriodicalId":15312,"journal":{"name":"中药材","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Preparation of Salviae Miltiorrhiza and Ligustrazine Hydrochloride Nasal Thermosensitive in Situ Gel and Study on Characterization of Its Nasal Mucosal Permeability].\",\"authors\":\"Wang-qing Hao, Yu Lin, Xu Yuan, Qian Gao\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To prepare the salviae miltiorrhiza and ligustrazine hydrochloride nasal thermosensitive in situ gel and to study the characterization of its nasal mucosal permeability.</p><p><strong>Methods: </strong>With gelling temperature as the dependent variable, the contents of poloxamer 407( P407), poloxamer 188( P188) and PEG-6000 as independent variables. The best prescription was optimized by central composite design-response surface methodology. The release in vitro and the skin permeation ability were evaluated in Franz diffusion cell.</p><p><strong>Results: </strong>The optimal formulation composed with the dosage of P407,P188 and PEG-6000 were 18%,7% and 1%,respectively. The cumulative release in vitro was over 70% after 12 h, and the release curve conformed to the first-order kinetic equation. The cumulative permeation of salviae miltiorrhiza and ligustrazine hydrochloride in the gel were 2 649. 77 μg / cm2 and 119. 72 μg / cm2 after 12h.</p><p><strong>Conclusion: </strong>The central composite design-response surface methodolog was stable and feasible for preparation of nasal thermosensitive in situ gel of salviae miltiorrhiza and ligustrazine hydrochloride, the drug-loaded gel has sustained release effect.</p>\",\"PeriodicalId\":15312,\"journal\":{\"name\":\"中药材\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中药材\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中药材","FirstCategoryId":"3","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Preparation of Salviae Miltiorrhiza and Ligustrazine Hydrochloride Nasal Thermosensitive in Situ Gel and Study on Characterization of Its Nasal Mucosal Permeability].
Objective: To prepare the salviae miltiorrhiza and ligustrazine hydrochloride nasal thermosensitive in situ gel and to study the characterization of its nasal mucosal permeability.
Methods: With gelling temperature as the dependent variable, the contents of poloxamer 407( P407), poloxamer 188( P188) and PEG-6000 as independent variables. The best prescription was optimized by central composite design-response surface methodology. The release in vitro and the skin permeation ability were evaluated in Franz diffusion cell.
Results: The optimal formulation composed with the dosage of P407,P188 and PEG-6000 were 18%,7% and 1%,respectively. The cumulative release in vitro was over 70% after 12 h, and the release curve conformed to the first-order kinetic equation. The cumulative permeation of salviae miltiorrhiza and ligustrazine hydrochloride in the gel were 2 649. 77 μg / cm2 and 119. 72 μg / cm2 after 12h.
Conclusion: The central composite design-response surface methodolog was stable and feasible for preparation of nasal thermosensitive in situ gel of salviae miltiorrhiza and ligustrazine hydrochloride, the drug-loaded gel has sustained release effect.
期刊介绍:
"Chinese Materia Medica" magazine was founded in 1978. It is a national-level academic journal of Chinese medicine science and technology approved by the State Science and Technology Commission and the Press and Publication Administration for public distribution at home and abroad. It is sponsored by the Chinese Materia Medica Information Center of the State Food and Drug Administration and is publicly distributed at home and abroad. It mainly reports on new technologies, new methods and new achievements in the production, scientific research and business management of Chinese medicine, and serves to promote the production and scientific and technological development of Chinese medicine, improve the output and quality of Chinese medicine, improve business management, and prosper the Chinese medicine industry.